Graham Capital Management, L.P. Adma Biologics, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 13,544 shares of ADMA stock, worth $267,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,544
Previous 31,274
56.69%
Holding current value
$267,087
Previous $206,000
26.7%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
295Shares Held
180MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$368 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$286 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$260 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$176 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$159 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...